Valneva to present its chikungunya vaccine candidate at the astmh 2021 annual meeting

Saint - herblain ( france), november 15 , 2021 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced it will present its chikungunya vaccine candidate, vla1553, on november 18 and 19, 2021 during the american society of tropical medicine & hygiene (astmh) 2021 annual meeting.
VALN Ratings Summary
VALN Quant Ranking